Umbilical cord blood serum procalcitonin by Time-Resolved Amplified Cryptate Emission (TRACE) technology: reference values of a potential marker of vertically transmitted neonatal sepsis : Clinical Chemical Laboratory Medicine Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue
Loading journal volume and issue information...

Umbilical cord blood serum procalcitonin by Time-Resolved Amplified Cryptate Emission (TRACE) technology: reference values of a potential marker of vertically transmitted neonatal sepsis

Elena Llorente1 / Belén Prieto2 / Leyre Cardo3 / Noelia Avello4 / Francisco V. Alvarez5

1Hospital Universitario Central de Asturias, Servicio de Bioquímica, Oviedo, Spain

2Hospital Universitario Central de Asturias, Servicio de Bioquímica, Oviedo, Spain

3Hospital Universitario Central de Asturias, Servicio de Bioquímica, Oviedo, Spain

4Hospital Universitario Central de Asturias, Servicio de Bioquímica, Oviedo, Spain

5Hospital Universitario Central de Asturias, Servicio de Bioquímica, Oviedo, Spain and Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, Oviedo, Spain

Corresponding author: Belén Prieto García, PhD, Hospital Universitario Central de Asturias, c/ Celestino Villamil, s/n – 33006 Oviedo, Spain Phone/Fax: +34-985-108073,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 45, Issue 11, Pages 1531–1535, ISSN (Online) 14374331, ISSN (Print) 14346621, DOI: 10.1515/CCLM.2007.304, October 2007

Publication History

Received:
2007-04-24
Accepted:
2007-07-08
Published Online:
2007-10-31

Abstract

Background: Neonatal infection remains a major diagnostic problem because of non-specific clinical signs and symptoms, as well as low sensitivity and specificity of routine laboratory tests. C-reactive protein (CRP), white blood cell count, absolute neutrophil count and immature/total neutrophil ratio are the most widely used tests in the diagnosis of sepsis and provide useful information, but none of these has demonstrated to be reliable in detecting all septic infants. Procalcitonin (PCT) has been suggested as a potentially useful laboratory test performed in umbilical cord blood when perinatal bacterial sepsis is under investigation.

Methods: In this study, the reference interval for umbilical cord blood serum PCT was established for the first time by Time-Resolved Amplified Cryptate Emission (TRACE) technology.

Results: The reference interval for PCT in umbilical cord blood serum ranged from 0.04 to 0.43 μg/L in 168 non-infected newborn infants (95% CI 0.02–0.06 and 0.35–0.60 μg/L, respectively). Cord blood serum PCT correctly classified one infected patient out of 90 newborn infants at risk of vertically transmitted sepsis and identified another neonate as a potentially infected patient despite having negative blood cultures. However, cord blood CRP misclassified 21 out of the 90 patients as infected neonates.

Conclusions: Cord blood PCT measured by TRACE is a potentially more useful early marker of neonatal sepsis than cord blood CRP.

Clin Chem Lab Med 2007;45:1531–5.

Keywords: cord blood serum; C-reactive protein; neonatal sepsis; procalcitonin

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Fumihiro Ochi, Takashi Higaki, Masaaki Ohta, Toshifumi Yamauchi, Mari Tezuka, Toshiyuki Chisaka, Tomozo Moritani, Hisamichi Tauchi, and Eiichi Ishii
Pediatrics International, 2015, Volume 57, Number 2, Page 263
[2]
Eva Steinberger, Nora Hofer, and Bernhard Resch
Scandinavian Journal of Clinical & Laboratory Investigation, 2014, Volume 74, Number 5, Page 432
[3]
Ying Fan and Jia-Lin Yu
World Journal of Pediatrics, 2012, Volume 8, Number 2, Page 101
[4]
H. Altunhan, A. Annagür, R. Örs, and I. Mehmetoğlu
International Journal of Infectious Diseases, 2011, Volume 15, Number 12, Page e854
[5]
Diego Miguel, Belén Prieto, Marta Costa, Daniel Coto, and Francisco V. Alvarez
Clinical Biochemistry, 2011, Volume 44, Number 4, Page 337
[6]
Kenneth L. Becker, Richard Snider, and Eric S. Nylen
Critical Care Medicine, 2008, Volume 36, Number 3, Page 941
[7]
Shmuel Arnon and Ita Litmanovitz
Current Opinion in Infectious Diseases, 2008, Volume 21, Number 3, Page 223

Comments (0)

Please log in or register to comment.